Clinical predictors of cardiovascular implantable electronic device-related XXXX .

@entity1 @entity281 @entity15243 @entity299 @entity221 @entity491 @entity884
BACKGROUND: Cardiovascular implantable electronic device (CIED)-related @entity884 (CIED-IE) is a serious complication of @entity299 and is associated with increased mortality. At present, there exist no criteria to predict CIED-IE in @entity1 who present with @entity15243 . METHODS: We retrospectively reviewed all cases of @entity15243 seen at Mayo Clinic Rochester between 1991 and 2008. CIED-IE was classified using pathologic and clinical criteria. Clinical predictors of CIED-IE were identified using logistic regression, and quantified using a summary score and plotted against the distribution of CIED-IE. RESULTS: Ninety-three (22.4%) of the 416 @entity1 with @entity15243 had CIED-IE. Host factors including chronic immunomodulator therapy exclusive of corticosteroid (odds ratio [OR], 3.79 [confidence interval (CI) 1.10, 13.04]), chronic corticosteroid therapy (OR, 2.15 [CI 0.93, 5.00]), hemodialysis (OR, 3.24 [CI 1.39, 7.55]), or remote @entity281 (OR, 1.77 [CI 0.99, 3.14]) were associated with increased odds of CIED-IE. @entity1 with CIED-IE were at increased odds of presenting with @entity221 (OR, 3.78 [CI 1.93, 7.40]), or malaise (OR, 1.87 [CI 1.02, 3.41]), and have findings of @entity491 (OR, 3.61 [CI 1.51, 8.62]). In marked contrast, they were at decreased odds of exhibiting signs/symptoms of @entity281 at the generator pocket site (OR, 0.19 [CI 0.10, 0.36]). Summary scores of 6 and 11 predicted CIED-IE in approximately 50% and 90% of cases, respectively. CONCLUSIONS: Certain comorbid conditions and systemic manifestations of @entity281 were associated with CIED-IE. In contrast, pocket site @entity281 was negatively associated with CIED-IE. These findings should assist clinicians in identifying @entity1 who would more likely benefit from further investigation of CIED-IE with transesophageal echocardiography.
